Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030
전 세계 수면무호흡증용 구강내 장치 시장 규모는 예측 기간 동안 9.8%의 CAGR로 확대되어 2025년 5억 달러에서 2030년에는 8억 달러에 달할 것으로 예상됩니다.
| 조사 범위 |
| 조사 대상 연도 |
2024-2030년 |
| 기준 연도 |
2024년 |
| 예측 기간 |
2024-2030년 |
| 검토 단위 |
금액(10억 달러) |
| 부문 |
제품별, 구입 유형별, 성별, 연령대별, 유통 채널별, 최종사용자별, 지역별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
당뇨병, 고혈압, 비만 등 생활습관병이 증가하면서 폐쇄성 수면무호흡증을 유발하여 호흡곤란을 유발할 수 있기 때문에 시장이 성장하고 있습니다. 또한, 수면무호흡증과 그 관리 및 치료법에 대한 인식이 높아지고 있습니다. 또한, 업계 선도 기업들은 혁신적인 제품을 도입하고 포트폴리오를 확장하고 있습니다. 이 회사들은 환자의 요구를 더 잘 충족시키기 위해 조정 가능한 다양한 첨단 비침습적 구강 장치를 제공하고 있습니다.
최종사용자별로 수면무호흡증 치료 기기 시장은 클리닉, 병원, 재택 요양기관/개인 등으로 구분되며, 2024년에는 재택 요양기관/개인 부문이 가장 큰 시장 점유율을 차지했습니다. 이 부문의 시장 성장에 기여하는 주요 요인으로는 입원에 비해 편리하고, 원격으로 사용할 수 있으며, 비용 효율성이 높기 때문에 이러한 환경에서 수면무호흡증 치료기를 사용하는 것이 선호된다는 점을 들 수 있습니다. 이러한 장비는 보험 및 상환 정책에 의해 보장됩니다. 재택의료 환경은 특히 북미와 유럽 등 선진국에서 수면무호흡증 유병률이 증가함에 따라 신흥 시장으로 성장하고 있습니다. 이러한 증가는 주로 이들 지역의 일반적인 생활습관 선택에 기인합니다. 또한, 집에서 쉽게 수면무호흡증 검사를 받을 수 있다는 점도 수면무호흡증 경구용 기기 시장의 성장에 크게 기여하고 있습니다.
유통 채널별로 수면무호흡증용 구강용품 시장은 온라인 약국, 소매 약국, 병원 약국 및 치과 진료소로 구분됩니다. 이 중 소매 약국이 2024년 가장 큰 시장 점유율을 차지한 것은 소매 약국에서 수면무호흡증용 구강내 기기의 가용성이 증가하고 있으며, 신흥 시장에서 이러한 환경이 조성되고 있기 때문으로 분석됩니다. 진단되지 않은 수면무호흡증과 관련된 위험에 대한 인식이 높아짐에 따라 구강내 기기에 대한 수요가 증가하고 있습니다. 그 결과, 소매 약국에서는 대기 시간이 제로가 되었고, 다양한 가격대와 품질로 다양한 기기가 제공되고 있습니다.
전 세계 수면무호흡증용 구강내 장치 시장은 5개 지역(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)으로 나뉘어져 있습니다. 아시아태평양은 수면무호흡증용 구강내 장치 시장에서 가장 빠르게 성장하고 있습니다. 아시아태평양 시장의 높은 성장률에 기여하는 주요 요인은 이 지역에 제조 및 유통 기업이 존재하기 때문입니다. 일부 주요 기업들은 최근 아시아태평양에서 구강 기기 제조 공장을 설립하여 입지를 확장하고 있습니다. 또한, 아시아태평양 시장의 헬스케어 분야의 인프라 및 기술 발전도 증가하고 있습니다.
세계의 수면무호흡증용 구강내 장치 시장을 조사했으며, 제품별, 구매 유형별, 성별, 연령대별, 유통 채널별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 주요 인사이트
제5장 시장 개요
- 소개
- 시장 역학
- 가격 분석
- 밸류체인 분석
- 공급망 분석
- 생태계 분석
- Porter's Five Forces 분석
- 규제 분석
- 무역 분석
- 특허 분석
- 2025-2026년의 주요 회의와 이벤트
- 고객의 비즈니스에 영향을 미치는 동향/혼란
- 주요 이해관계자와 구입 기준
- 수면무호흡증용 구강내 장치 시장에서 생성형 AI의 영향
- 투자와 자금 조달 시나리오
- 기술 분석
- 최종사용자 인식 분석
- 구입 의사결정 프로세스
- 수면무호흡증용 구강내 장치 시장에 대한 트럼프 관세의 영향
제6장 수면무호흡증용 구강내 장치 시장(제품별)
- 소개
- 하악 전진 장치
- 혀 유지 장치
- 밤낮 겸용 장치
제7장 수면무호흡증용 구강내 장치 시장(구입 유형별)
- 소개
- 의사가 처방한/맞춤형 구강내 장치
- 온라인 OTC 구강내 장치
제8장 수면무호흡증용 구강내 장치 시장(성별)
제9장 수면무호흡증용 구강내 장치 시장(연령층별)
제10장 수면무호흡증용 구강내 장치 시장(유통 채널별)
- 소개
- 온라인 약국
- 소매 약국
- 병원 약국과 치과의원
제11장 수면무호흡증용 구강내 장치 시장(최종사용자별)
제12장 수면무호흡증용 구강내 장치 시장(지역별)
- 소개
- 북미
- 유럽
- 유럽의 거시경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타
- 아시아태평양
- 아시아태평양의 거시경제 전망
- 중국
- 일본
- 호주
- 기타
- 라틴아메리카
- 열악한 의료 서비스 및 시장을 억제하는 공중 보건 노력 부족
- 라틴아메리카의 거시경제 전망
- 중동 및 아프리카
- 주요 국제적 진출 기업의 존재와 만성질환의 높은 발생률이 시장을 견인
- 중동 및 아프리카의 거시경제 전망
- GCC 국가
- 높은 여성 비만율이 시장 성장을 뒷받침
- GCC 국가의 거시경제 전망
제13장 경쟁 구도
- 개요
- 주요 진출 기업 전략/강점
- 매출 분석, 2022-2024년
- 시장 점유율 분석, 2024년
- 기업 평가 매트릭스 : 주요 진출 기업, 2024년
- 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
- 기업 평가와 재무 지표
- 브랜드/제품 비교
- 경쟁 시나리오
제14장 기업 개요
- 주요 진출 기업
- SOMNOMED
- RESMED
- PROSOMNUS SLEEP TECHNOLOGIES
- DYNAFLEX
- VIVOS THERAPEUTICS, INC.
- OPENAIRWAY
- PANTHERA DENTAL
- AIRWAY MANAGEMENT
- APNEA SCIENCES
- ORAVANOSA
- MYERSON LLC.
- BRAEBON MEDICAL CORPORATION
- 기타 기업
- MPOWRX HEALTH & WELLNESS PRODUCTS
- THE SNORE RELIEVER COMPANY, LLC
- TOMED GMBH
- THE AURUM GROUP
- ERKODENT ENRICH KOPP GMBH
- OSCIMED SA
- SICAT GMBH & CO. KG
- GLIDEWELL
- APNOMED, INC.
- ZQUIET
- DREAM SYSTEMS DENTAL SLEEP LAB
- ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC
- ORTHOAPNEA
- DOC BRANDS, INC.
제15장 부록
ksm
The global sleep apnea oral appliances market is projected to reach USD 0.8 billion by 2030 from USD 0.5 billion in 2025, at a CAGR of 9.8% during the forecast period.
| Scope of the Report |
|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2024-2030 |
| Units Considered | Value (USD billion) |
| Segments | Product, Gender, Purchase Type, Age Group, Distribution Channel, End User, and Region |
| Regions covered | North America, Europe, APAC, LATAM, MEA |
The market is experiencing growth due to a rise in lifestyle-related disorders such as diabetes, hypertension, and obesity, which can lead to obstructive sleep apnea and make it difficult for patients to breathe. There is also a growing awareness of sleep apnea and its management and treatment options. Furthermore, leading players in the industry are introducing innovative products and expanding their portfolios. These companies offer a variety of advanced, non-invasive oral appliances that are adjustable to meet patients' needs better.
By end user, the home care settings/individuals segment is expected to dominate the market during the forecast period.
By end users, the sleep apnea appliances market is segmented into clinics, hospitals, and home care settings/individuals. The home care settings/individuals segment accounted for the largest share of the market in 2024. The key factor contributing to market growth in this segment includes the preference of adopting sleep apnea devices in these settings owing to ease of convenience, remote availability, and cost-efficiency compared to hospitalization. These devices are covered by insurance or reimbursement policies. The home care setting is a growing market due to the increasing prevalence of sleep apnea, particularly in developed regions like North America and Europe. This rise is primarily attributed to the lifestyle choices common in these areas. Additionally, the accessibility of home sleep apnea tests is a significant factor contributing to the growth of the sleep apnea oral appliances market.
By distribution channel, the retail pharmacies segment accounted for the largest market share in 2024.
By distribution channel, the sleep apnea oral appliances market is divided into online pharmacies, retail pharmacies, and hospital pharmacies & dental clinics. Among these, the retail pharmacies segment accounted for the largest market share in 2024 owing to the increasing availability of oral sleep apnea appliances in retail pharmacies and the rising establishment of these settings in emerging markets. There is a growing awareness of the risks associated with undiagnosed sleep apnea, leading to an increased demand for oral appliances. This has resulted in zero waiting times at retail pharmacies, which offer a variety of devices that vary in affordability and quality.
The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
The global sleep apnea oral appliances market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest-growing regional sleep apnea organ appliance market. The key factors contributing to the high growth rate of the Asia Pacific market are the presence of manufacturing & distribution companies in the region. Some key players have recently expanded their presence in the Asia Pacific by setting up a manufacturing plant for oral appliances. Additionally, advancements in infrastructure and technology in the healthcare sector in the Asia Pacific market are increasing.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-40%, Tier 2-50%, and Tier 3- 10%
- By Designation: C-level-48%, Director-level-37% and Others-15%
- By Region: North America-46%, Europe-26%, Asia Pacific-15%, Latin America- 6%, the Middle East & Africa - 4%, and GCC Countries - 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The leading players operating in the sleep apnea oral appliances market are SomnoMed (Australia), Resmed (US), ProSomnus Sleep Technologies (US), DynaFlex (US), Vivos Therapeutics, Inc. (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC (US), and Braebon Medical Corporation (Canada).
Research Coverage
This report studies the sleep apnea oral appliances market based on product, gender, purchase type, age group, distribution channel, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments about five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help established and new or smaller firms understand the market dynamics, allowing them to capture a larger market share. Companies that purchase the report can implement one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (Large pool of undiagnosed sleep apnea patients globally, growing awareness about effects of untreated sleep apnea among patients, rising usage of oral appliances among patients with mild-to-moderate sleep apnea, and the increasing number of companies in sleep apnea devices and oral appliances market), restraints (high prices of customized oral appliances, alternative therapies and medications for sleep apnea, risks associated with oral appliance therapy for obstructive sleep apnea), opportunities (growing demand for home sleep apnea tests as cost-saving measures; increasing focus on telemedicine, mhealth, and AI; poor compliance associated with CPAP) and challenges (complex referral pathways and long waiting periods) influencing the growth of the sleep apnea oral appliances market)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the sleep apnea oral appliances market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the sleep apnea oral appliances market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the sleep apnea oral appliances market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED & GEOGRAPHIC SPREAD
- 1.3.2 YEARS CONSIDERED
- 1.3.3 CURRENCY CONSIDERED
- 1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Primary sources
- 2.1.2.2 Key industry insights
- 2.1.2.3 Key data from primary sources
- 2.1.2.4 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Approach 1: Company revenue estimation approach
- 2.2.1.2 Approach 2: Presentations of companies and primary interviews
- 2.2.1.3 Approach 3: Primary interviews
- 2.2.1.4 Approach 4: Growth Forecast
- 2.2.1.5 CAGR projections
- 2.2.2 TOP-DOWN APPROACH
- 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.4 RESEARCH LIMITATIONS
- 2.5 RESEARCH ASSUMPTIONS
- 2.5.1 STUDY-RELATED ASSUMPTIONS
- 2.5.2 GROWTH RATE ASSUMPTIONS
- 2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW
- 4.2 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030
- 4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2024)
- 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Large pool of undiagnosed sleep apnea patients
- 5.2.1.2 Growing awareness associated with effects of untreated sleep apnea
- 5.2.1.3 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
- 5.2.1.4 Entry of established companies with advanced sleep apnea oral solutions
- 5.2.2 RESTRAINTS
- 5.2.2.1 High price of customized oral appliances
- 5.2.2.2 Alternative therapies & medications for sleep apnea
- 5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising demand for at-home sleep apnea tests
- 5.2.3.2 Increasing importance of telemedicine, mHealth, and AI
- 5.2.3.3 Poor compliance and low adherence associated with CPAP
- 5.2.4 CHALLENGES
- 5.2.4.1 Complex referral pathways and long waiting periods
- 5.3 PRICING ANALYSIS
- 5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
- 5.3.2 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023-2025
- 5.3.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023-2025
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 ECOSYSTEM ANALYSIS
- 5.7 PORTER'S FIVE FORCES ANALYSIS
- 5.7.1 THREAT OF NEW ENTRANTS
- 5.7.2 THREAT OF SUBSTITUTES
- 5.7.3 BARGAINING POWER OF SUPPLIERS
- 5.7.4 BARGAINING POWER OF BUYERS
- 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.8 REGULATORY ANALYSIS
- 5.8.1 REGULATORY LANDSCAPE
- 5.8.1.1 North America
- 5.8.1.1.1 US
- 5.8.1.1.1.1 Reimbursement scenario in US
- 5.8.1.1.2 Canada
- 5.8.1.2 Europe
- 5.8.1.3 Asia Pacific
- 5.8.1.3.1 Japan
- 5.8.1.3.2 China
- 5.8.1.3.3 India
- 5.8.1.3.4 Australia
- 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.8.2.1 North America
- 5.8.2.2 Europe
- 5.8.2.3 Asia Pacific
- 5.8.2.4 Latin America
- 5.8.2.5 Middle East & Africa
- 5.9 TRADE ANALYSIS
- 5.9.1 TRADE ANALYSIS FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES
- 5.10 PATENT ANALYSIS
- 5.11 KEY CONFERENCES & EVENTS, 2025-2026
- 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 BUYING CRITERIA
- 5.14 IMPACT OF GENERATIVE AI ON SLEEP APNEA ORAL APPLIANCES MARKET
- 5.14.1 INTRODUCTION
- 5.14.2 MARKET POTENTIAL FOR SLEEP APNEA ORAL APPLIANCES
- 5.14.3 FUTURE OF GENERATIVE AI IN SLEEP APNEA ORAL APPLIANCES MARKET
- 5.15 INVESTMENT & FUNDING SCENARIO
- 5.16 TECHNOLOGY ANALYSIS
- 5.16.1 KEY TECHNOLOGIES
- 5.16.1.1 Mandibular advancement devices
- 5.16.2 ADJACENT TECHNOLOGIES
- 5.16.2.1 Daytime-nighttime appliances
- 5.17 END-USER PERCEPTION ANALYSIS
- 5.18 PURCHASE DECISION-MAKING PROCESS
- 5.18.1 INTRODUCTION
- 5.18.1.1 Need recognition
- 5.18.1.2 Gathering information
- 5.18.1.3 Evaluating alternatives
- 5.19 TRUMP TARIFF IMPACT ON SLEEP APNEA ORAL APPLIANCES MARKET
- 5.19.1 INTRODUCTION
- 5.19.2 KEY TARIFF RATES
6 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 MANDIBULAR ADVANCEMENT DEVICES
- 6.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES
- 6.2.1.1 Low cost of ready-made MADs to boost demand
- 6.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES
- 6.2.2.1 High efficacy of custom-made MADs to support market growth
- 6.3 TONGUE-RETAINING DEVICES
- 6.3.1 LOWER SUCCESS RATE OF TRDS TO HINDER MARKET GROWTH
- 6.4 DAYTIME-NIGHTTIME APPLIANCES
- 6.4.1 INCREASING COMFORT & CONVENIENCE TO FUEL MARKET
7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE
- 7.1 INTRODUCTION
- 7.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES
- 7.2.1 FAILURE ASSOCIATED WITH CPAP THERAPY TO BOOST DEMAND
- 7.3 ONLINE OTC ORAL APPLIANCES
- 7.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH
8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER
- 8.1 INTRODUCTION
- 8.2 MALE PATIENTS
- 8.2.1 INHERENT DIFFERENCES IN BODY ANATOMY TO FUEL UPTAKE
- 8.3 FEMALE PATIENTS
- 8.3.1 GROWING AWARENESS FOR IMPROVED DIAGNOSIS TO SUPPORT MARKET
9 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP
- 9.1 INTRODUCTION
- 9.2 BELOW 40 YEARS
- 9.2.1 LOWER PREVALENCE OF OSA IN YOUNGER AGE GROUPS TO RESTRAIN MARKET
- 9.3 BETWEEN 40-60 YEARS
- 9.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH
- 9.4 ABOVE 60 YEARS
- 9.4.1 AGE-ASSOCIATED DISORDERS TO SUPPORT MARKET GROWTH
10 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL
- 10.1 INTRODUCTION
- 10.2 ONLINE PHARMACIES
- 10.2.1 RISING BENEFITS OFFERED BY E-COMMERCE TO PROPEL MARKET
- 10.3 RETAIL PHARMACIES
- 10.3.1 RISING ACCESSIBILITY TO WIDE RANGE OF ORAL APPLIANCES TO BOOST DEMAND
- 10.4 HOSPITAL PHARMACIES & DENTAL CLINICS
- 10.4.1 PROVISION OF MAD AND TRD DEVICES DURING ORAL PROCEDURES TO SUPPORT MARKET GROWTH
11 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 HOME CARE SETTINGS/INDIVIDUALS
- 11.2.1 GROWING PATIENT PREFERENCE FOR REMOTE OSA SERVICES TO PROPEL MARKET
- 11.3 HOSPITALS
- 11.3.1 ABILITY TO PURCHASE ADVANCED SLEEP APNEA EQUIPMENT TO DRIVE MARKET
- 11.4 DENTAL CLINICS
- 11.4.1 INCREASING ESTABLISHMENT OF PRIVATE DENTAL PRACTICES TO SUPPORT MARKET GROWTH
12 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 12.2.2 US
- 12.2.2.1 Favorable reimbursements and regulatory support to fuel market
- 12.2.3 CANADA
- 12.2.3.1 Increasing number of research grants for awareness of sleep disorders to drive market
- 12.3 EUROPE
- 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 12.3.2 GERMANY
- 12.3.2.1 High prevalence of smokers and favorable health insurance coverage to fuel market
- 12.3.3 UK
- 12.3.3.1 Rising awareness among patients and increasing number of sleep service groups to support market
- 12.3.4 FRANCE
- 12.3.4.1 Expanding geriatric population and growing awareness of early diagnosis for OSA to drive market
- 12.3.5 ITALY
- 12.3.5.1 High prevalence of obesity and CVD to fuel market
- 12.3.6 SPAIN
- 12.3.6.1 Growing focus on telemedicine and remote monitoring of OSA patients to drive market
- 12.3.7 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 12.4.2 CHINA
- 12.4.2.1 Rising geriatric population and increasing cases of obesity to boost demand
- 12.4.3 JAPAN
- 12.4.3.1 Rising demand for cloud-connected sleep apnea therapeutic devices to fuel uptake
- 12.4.4 AUSTRALIA
- 12.4.4.1 Launch of technologically advanced OSA devices to aid market growth
- 12.4.5 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 POOR HEALTHCARE INFRASTRUCTURE AND LIMITED PUBLIC HEALTH INITIATIVES TO RESTRAIN MARKET
- 12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
- 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 12.7 GCC COUNTRIES
- 12.7.1 HIGH OBESITY RATE AMONG WOMEN TO SUPPORT MARKET GROWTH
- 12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
13 COMPETITIVE LANDSCAPE
- 13.1 OVERVIEW
- 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET
- 13.3 REVENUE ANALYSIS, 2022-2024
- 13.4 MARKET SHARE ANALYSIS, 2024
- 13.4.1 RANKING OF KEY MARKET PLAYERS
- 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 13.5.5.1 Company footprint
- 13.5.5.2 Region footprint
- 13.5.5.3 Product footprint
- 13.5.5.4 Purchase type footprint
- 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 13.6.5.1 Detailed list of key startups/SMEs
- 13.6.5.2 Competitive benchmarking of key startups/SMEs
- 13.7 COMPANY VALUATION AND FINANCIAL METRICS
- 13.7.1 COMPANY VALUATION
- 13.7.2 FINANCIAL METRICS
- 13.8 BRAND/PRODUCT COMPARISON
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES & APPROVALS
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
- 13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 SOMNOMED
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 MnM view
- 14.1.1.3.1 Key strengths
- 14.1.1.3.2 Strategic choices
- 14.1.1.3.3 Weaknesses & competitive threats
- 14.1.2 RESMED
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.2.1 Deals
- 14.1.2.2.2 Expansions
- 14.1.2.3 MnM view
- 14.1.2.3.1 Key strengths
- 14.1.2.3.2 Strategic choices
- 14.1.2.3.3 Weaknesses & competitive threats
- 14.1.3 PROSOMNUS SLEEP TECHNOLOGIES
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 Recent developments
- 14.1.3.4 MnM view
- 14.1.3.4.1 Key strengths
- 14.1.3.4.2 Strategic choices
- 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 DYNAFLEX
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.4.3 Recent developments
- 14.1.5 VIVOS THERAPEUTICS, INC.
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.5.3 Recent developments
- 14.1.5.3.1 Product approvals
- 14.1.5.3.2 Deals
- 14.1.5.3.3 Expansions
- 14.1.5.3.4 Other developments
- 14.1.6 OPENAIRWAY
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.6.3 Recent developments
- 14.1.7 PANTHERA DENTAL
- 14.1.7.1 Business overview
- 14.1.7.2 Products offered
- 14.1.7.3 Recent developments
- 14.1.7.3.1 Product launches
- 14.1.7.3.2 Deals
- 14.1.7.3.3 Other developments
- 14.1.8 AIRWAY MANAGEMENT
- 14.1.8.1 Business overview
- 14.1.8.2 Products offered
- 14.1.8.3 Recent developments
- 14.1.8.3.1 Product launches
- 14.1.9 APNEA SCIENCES
- 14.1.9.1 Business overview
- 14.1.9.2 Products offered
- 14.1.10 ORAVANOSA
- 14.1.10.1 Business overview
- 14.1.10.2 Products offered
- 14.1.11 MYERSON LLC.
- 14.1.11.1 Business overview
- 14.1.11.2 Products offered
- 14.1.12 BRAEBON MEDICAL CORPORATION
- 14.1.12.1 Business overview
- 14.1.12.2 Products offered
- 14.2 OTHER PLAYERS
- 14.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
- 14.2.2 THE SNORE RELIEVER COMPANY, LLC
- 14.2.3 TOMED GMBH
- 14.2.4 THE AURUM GROUP
- 14.2.5 ERKODENT ENRICH KOPP GMBH
- 14.2.6 OSCIMED SA
- 14.2.7 SICAT GMBH & CO. KG
- 14.2.8 GLIDEWELL
- 14.2.9 APNOMED, INC.
- 14.2.10 ZQUIET
- 14.2.11 DREAM SYSTEMS DENTAL SLEEP LAB
- 14.2.12 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC
- 14.2.13 ORTHOAPNEA
- 14.2.14 DOC BRANDS, INC.
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS
